The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.

Every technological revolution has a defining moment when a specific use case propels the technology into widespread adoption. That time has come for generative AI (GenAI) with the rapid spread of ...

The arrival of Industry 5.0 has opened up the ability for manufacturers to "see" in real-time the detailed relationship of ...

Financial GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs 05.02.2025 / 15:06 CET/CEST The issuer is solely responsible for the content of this ...

CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, confirms that, in accordance with the provisions of the ...

Convergence of AI and IoT will fundamentally reshape the digital economy in 2025, and beyond, by creating smarter, more ...

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of ...

Equities researchers at B. Riley dropped their Q4 2025 EPS estimates for Lam Research in a research note issued on Thursday, January 30th. B. Riley analyst C. Ellis now forecasts that the ...

Cantor Fitzgerald upgraded shares of Lam Research (NASDAQ:LRCX – Free Report) from a neutral rating to an overweight rating in a research note issued to investors on Thursday morning, MarketBeat.com ...

Orchard Therapeutics to Receive WORLDSymposium™ New Treatment Award ...